Skip to Main Content

Paper Details

Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study.
Clin Pharmacol Ther
13
2019
Author NameAffiliation
Alyson L DicksonVanderbilt University Medical Center
Megan M ShueyVanderbilt University Medical Center
QiPing FengVanderbilt University Medical Center
Wei-Qi WeiVanderbilt University Medical Center
Charles M SteinVanderbilt University Medical Center
Charles M SteinVanderbilt University Medical Center
  • 1 - 6

Datasets

Release 1.2